Yumi N. Imai
Fujisawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists.
Journal: ChemMedChem
Published: July 12, 2019
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: February 14, 2017
Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities.
Journal: Journal of medicinal chemistry
Published: March 09, 2016
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
Journal: Bioorganic & medicinal chemistry
Published: February 01, 2015
Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
Journal: Journal of medicinal chemistry
Published: November 13, 2013
Effective control of Epstein-Barr virus infection following pediatric liver transplantation by monitoring of viral DNA load and lymphocyte surface markers.
Journal: Pediatric transplantation
Published: July 07, 2012
Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.
Journal: Journal of medicinal chemistry
Published: April 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026